Company Monitoring Page for Acorda-Therapeutics

latest headlines for company on cafepharma

Biotech Drugs to Watch In 2010
Minyanville
Thu, 01/7/10 - 11:14 am
Tags:
Arena Pharmaceuticals, Vivus, Orexigen, Novo Nordisk, Amylin, Eli Lilly, Biogen Idec, Acorda Therapeutics, Dendreon, MannKind
Biotech's Best Quotes Go Straight to the Heart of 2009 Industry Trends
BNET Pharma
Tue, 01/5/10 - 12:11 pm
Tags:
biotech, Acorda Therapeutics, Kalos, Arena Pharmaceuticals
Biotech Calendar: Upcoming FDA Dates
TheStreet.com
Tue, 12/15/09 - 08:54 am
Tags:
FDA, Dendreon, Arena Pharmaceuticals, Chelsea Therapeutics, Cephalon, Biodel, Auxilium, Novartis, Novo Nordisk, Shire, Vivus, MannKind, Acorda Therapeutics
FDA delays ruling on Acorda's MS drug until Jan. 22
Yahoo/AP
Thu, 10/22/09 - 09:13 am
Tags:
Acorda Therapeutics, FDA, MS, multiple sclerosis, Fampridine-SR
FDA Panel Votes 'Yes' on Acorda Drug Efficacy
TheStreet.com
Wed, 10/14/09 - 08:14 pm
Tags:
Acorda Therapeutics, FDA, Biogen Idec, Amaya
A Mixed Bag for Traders and Investors in Healthcare
Seeking Alpha
Mon, 10/12/09 - 06:02 pm
Tags:
Acorda Therapeutics, Spectrum Pharmaceuticals, Cytori, Cryo-Cell, Novavax
Stage Set for Acorda Bounce?
Seeking Alpha
Mon, 10/12/09 - 11:18 am
Tags:
Acorda Therapeutics, Biogen Idec
Avanir, Acorda move on MS drug updates
Market Watch
Sat, 10/10/09 - 12:37 pm
Tags:
Avanir, Acorda Therapeutics, MS
Acorda’s MS Drug May Need More Study, U.S. FDA Says
Bloomberg
Fri, 10/9/09 - 09:29 am
Tags:
Acorda Therapeutics, MS, multiple sclerosis, Fampridine-SR
Acorda Therapeutics cites additional positive safety data on multiple sclerosis drug
Yahoo/AP
Tue, 09/15/09 - 07:47 pm
Tags:
Acorda Therapeutics, multiple sclerosis, MS, Fampridine-SR
Biogen Maintains Facet Offer
Yahoo/Zacks.com
Thu, 09/10/09 - 08:52 am
Tags:
Biogen Idec, Facet Biotech, M&A, Acorda Therapeutics, Bristol-Myers Squibb
Acorda confirms FDA panel review date for MS drug
Yahoo/AP
Tue, 08/25/09 - 12:21 pm
Tags:
Acorda Therapeutics, MS, FDA, multiple sclerosis, Fampridine-SR
Biogen Profit Falls on Cost of Acorda Partnership
Bloomberg
Thu, 07/16/09 - 08:54 am
Tags:
Biogen Idec, earnings, Acorda Therapeutics
Dealmaking Sweeps the Biotech Sector
Seeking Alpha
Sun, 07/5/09 - 06:02 pm
Tags:
JNJ, Elan, Cell Genesys, CombinatoRx, Acorda Therapeutics, BioSante, Biogen Idec, Geron, Roche, Mylan, Wyeth
Biogen Buys Rights to Acorda’s MS Pill Outside U.S.
Bloomberg
Wed, 07/1/09 - 09:04 am
Tags:
Biogen Idec, Acorda Therapeutics, Fampridine-SR, MS
We're Positive on Acorda
Yahoo/Zacks.com
Tue, 06/23/09 - 08:35 am
Tags:
Acorda Therapeutics, Fampridine-SR
Q1 2009 Biotech Earnings Roundup: The Good, the Bad, and the Ugly
Seeking Alpha
Wed, 05/27/09 - 07:38 am
Tags:
Gilead Sciences, Amgen, Human Genome Sciences, Acorda Therapeutics, Biomarin, Amag Pharmaceuticals, Biogen Idec, Genzyme, Cougar Biotechnology, JNJ, OSI Pharmaceuticals, Cephalon, Allergan, Celgene, Myriad, Sequenom, Auxilium
Acorda Pops On Good News
Yahoo/Zacks.com
Wed, 05/6/09 - 06:09 pm
Tags:
Acorda Therapeutics, Biogen Idec, Pfizer, Sanofi
Why I Doubt the FDA Will Approve Acorda's Fampridine
Seeking Alpha
Fri, 04/24/09 - 06:14 am
Tags:
Acorda Therapeutics, FDA, Fampiridine, antihypertensives
FDA, Clinical Trial Calendar Updates: Acorda, Alkermes, GTx
Seeking Alpha
Thu, 04/23/09 - 10:04 am
Tags:
FDA, drug trials, Acorda Therapeutics, GTx, Alkermes

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.